Table 3.
OR (95% CI) | p value | |
---|---|---|
Male sex | 1.13 (0.81–1.56) | 0.472 |
Age | 1.06 (1.04–1.08) | < 0.001 |
Diabetes | 1.34 (0.97–1.84) | 0.073 |
Previous mRS | ||
mRS-0 | REF | REF |
mRS-1 | 1.48 (0.98–2.21) | 0.006 |
mRS-2 | 1.59 (1.06–2.36) | 0.024 |
Baseline NIHSS | 1.17 (1.15–1.20) | < 0.001 |
Treatment | ||
No treatment | REF | REF |
Endovascular treatment | 0.73 (0.41–1.28) | 0.281 |
Endovascular + rTPA | 0.56 (0.38–0.83) | 0.004 |
ACR | 1.10 (1.05–1.15) | < 0.001 |
Values represent Odds Ratios (OR), 95% confidence intervals and p-values
ACR: acute-to-chronic glycaemic ratio; NIHSS: National Institutes of Health Stroke Scale; rtPA: recombinant tissue plasminogen activator